ZA927503B - Method for preventing allograft rejection. - Google Patents

Method for preventing allograft rejection.

Info

Publication number
ZA927503B
ZA927503B ZA927503A ZA927503A ZA927503B ZA 927503 B ZA927503 B ZA 927503B ZA 927503 A ZA927503 A ZA 927503A ZA 927503 A ZA927503 A ZA 927503A ZA 927503 B ZA927503 B ZA 927503B
Authority
ZA
South Africa
Prior art keywords
allograft rejection
preventing allograft
preventing
rejection
allograft
Prior art date
Application number
ZA927503A
Other languages
English (en)
Inventor
Mitsuaki Isobe
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of ZA927503B publication Critical patent/ZA927503B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA927503A 1991-10-01 1992-09-30 Method for preventing allograft rejection. ZA927503B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76804491A 1991-10-01 1991-10-01

Publications (1)

Publication Number Publication Date
ZA927503B true ZA927503B (en) 1993-05-03

Family

ID=25081356

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA927503A ZA927503B (en) 1991-10-01 1992-09-30 Method for preventing allograft rejection.

Country Status (8)

Country Link
EP (1) EP0610298A1 (fr)
JP (1) JPH07502727A (fr)
AU (1) AU667487B2 (fr)
CA (1) CA2120500A1 (fr)
HU (1) HUT69725A (fr)
MX (1) MX9205637A (fr)
WO (1) WO1993006864A1 (fr)
ZA (1) ZA927503B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
ATE151642T1 (de) * 1992-02-12 1997-05-15 Biogen Inc Behandlung für entzündungserkrankung des darmes
WO1994004188A1 (fr) * 1992-08-21 1994-03-03 Genentech, Inc. Procede pour traiter une affection ayant pour origine l'antigene 1 associe a la fonction lymphocytaire
US5817515A (en) * 1993-12-23 1998-10-06 Icos Corporation Human B2 integrin alpha subunit antibodies
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
AU2001230920A1 (en) * 2000-01-14 2001-07-24 Genentech Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
CA2454618C (fr) 2001-07-24 2012-04-03 Biogen Idec Ma, Inc. Methodes de traitement ou de prevention de troubles sclereux par l'usage d'agents se liant a cd2
WO2005115436A1 (fr) 2004-05-07 2005-12-08 Astellas Us Llc Polypeptide lfa-3 soluble destine a traiter de troubles viraux
AU2005254980A1 (en) 2004-06-09 2005-12-29 Genentech, Inc. Method of treating granuloma annulare or sarcoid
EP2102367A2 (fr) 2006-11-09 2009-09-23 XDX, Inc. Procedes pour diagnostiquer et surveiller l'etat d'un lupus erythemateux systemique

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852374T2 (de) * 1987-11-02 1995-05-04 Baylor College Medicine Verwendung von ICAM-1 oder ihre funktionelle Derivate zur Behandlung unspezifischer Entzündungen.
ATE246245T1 (de) * 1988-09-28 2003-08-15 Dana Farber Cancer Inst Inc Interzellulare adhäsions-moleküle und deren bindungsliganden
ATE142505T1 (de) * 1988-11-14 1996-09-15 Brigham & Womens Hospital Antikörper, spezifisch gegen elam-1 sowie deren verwendung
EP0387701B1 (fr) * 1989-03-09 1992-08-12 Boehringer Ingelheim Pharmaceuticals Inc. Utilisation des molécules d'adhésion intercellulaire et leurs ligands de liaison dans le traitement de l'asthme
AU5553290A (en) * 1989-04-28 1990-11-29 Baylor College Of Medicine Dissemination of hiv-1 infected cells
US5011778A (en) * 1989-05-23 1991-04-30 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method

Also Published As

Publication number Publication date
EP0610298A1 (fr) 1994-08-17
AU667487B2 (en) 1996-03-28
MX9205637A (es) 1993-05-01
AU2782992A (en) 1993-05-03
HUT69725A (en) 1995-09-28
CA2120500A1 (fr) 1993-04-15
JPH07502727A (ja) 1995-03-23
WO1993006864A1 (fr) 1993-04-15
HU9400930D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
ZA917163B (en) Filtration arrangement and method.
HK1010191A1 (en) Method for manufacturing anti-viral compounds.
EP0656319A3 (fr) Procédé pour production de poudre d'alumine-alpha.
EP0605240A3 (fr) Appareil de focalisation automatique.
EP0655212A3 (fr) Machine automatique pour préparer des boissons.
EP0568269A3 (fr) Diode et méthode pour sa fabrication.
EP0663554A3 (fr) Bague avec patins de glissement et méthode pour sa fabrication.
EP0595233A3 (fr) Procédé de fabrication d'un semiconducteur sur isolant.
EP0625781A3 (fr) Appareil de montage.
ZA922313B (en) Anticoagulants and processes for preparing such.
EP0626410A3 (fr) Procédé pour la préparation de polycarbonates.
EP0604025A3 (fr) Procédé de formation d'images.
ZA927503B (en) Method for preventing allograft rejection.
EP0589725A3 (fr) Méthode thermosensible pour former des images.
EP0578093A3 (fr) Procédé de formation d'images.
ZA925463B (en) Method for the manufacture of tall oils.
EP0656067A4 (fr) Procedes de depistage d'agents immunosuppressifs.
EP0646846A3 (fr) Procédé de formation d'image.
EP0585529A3 (fr) Palier de support.
EP0607696A3 (fr) Procédé de traitement d'image.
ZA93782B (en) Determination method.
AU2323492A (en) Method for inhibiting allograft rejection
EP0644805A1 (fr) Machine-outil automatique travaillant par formage.
EP0599142A3 (fr) Méthode de fabrication d'immunoconjugués.
EP0578138A3 (fr) Méthode pour la détection de gènes.